EMA: Draft GL for OIPs [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2024-04-19 17:40 (443 d 05:49 ago) – Posting: # 23959
Views: 4,238

Dear all,

as a birthday gift the EMA published a

Draft guideline on the requirements for demonstrating therapeutic equivalence between orraly inhaled products (OIP) for asthma and chronic obstructive pulmonary disease (COPD).

Consultation is open until 30 October 2024.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,678 registered users;
39 visitors (0 registered, 39 guests [including 11 identified bots]).
Forum time: 23:29 CEST (Europe/Vienna)

Many people tend to look at programming styles and languages like religions:
if you belong to one, you cannot belong to others.
But this analogy is another fallacy.    Niklaus Wirth

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5